4.3 Article

Clinical Evaluation of IDH Mutation Status in Formalin-Fixed Paraffin-Embedded Tissue in Gliomas

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Improving Time-to-Treatment for Advanced Non-Small Cell Lung Cancer Patients through Faster Single Gene EGFR Testing Using the Idylla™ EGFR Testing Platform

Norbert Banyi et al.

Summary: The use of Idylla EGFR testing in advanced-stage NSCLC patients could significantly reduce time-to-treatment (TTT). Compared to genetic testing methods, Idylla testing showed a faster turnaround time (TAT) and a high concordance frequency with NGS panel testing. For EGFR-positive patients, the use of Idylla testing led to a 48% reduction in TTT.

CURRENT ONCOLOGY (2022)

Review Biochemistry & Molecular Biology

Prognostic and Predictive Biomarkers in Gliomas

Paulina Sledzinska et al.

Summary: The latest research on prognostic and predictive biomarkers in gliomas has been compiled, highlighting the importance of prognostic markers in adult and pediatric patients and the clinical significance in predicting treatment responses. Further work is needed to implement novel technologies such as liquid biopsies in clinical practice.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Medicine, General & Internal

Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers

Eric J. Duncavage et al.

Summary: This study showed that whole-genome sequencing provided rapid and accurate genomic profiling in patients with AML or MDS, with a greater diagnostic yield than conventional cytogenetic analysis, and more efficient risk stratification based on standard risk categories.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Review Cell Biology

The Roles of 2-Hydroxyglutarate

Xin Du et al.

Summary: 2-HG plays a significant role in 2-hydroxyglutaric aciduria, tumors with IDH1/2mt mutations, and ccRCC, being regarded as an oncometabolite. It can also accumulate in hypoxic or acidic pH conditions, and has been shown to have a vital role in the fate decision of immune cells.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Oncology

Ivosidenib in Isocitrate Dehydrogenase 1-Mutated Advanced Glioma

Ingo K. Mellinghoff et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

Review Anatomy & Morphology

Determining IDH-Mutational Status in Gliomas Using IDH1-R132H Antibody and Polymerase Chain Reaction

Dibson D. Gondim et al.

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2019)

Review Chemistry, Medicinal

Development of Novel Therapeutics Targeting Isocitrate Dehydrogenase Mutations in Cancer

Horrick Sharma

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2018)

Article Neurosciences

Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnostics

Nathalie E. Synhaeve et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)

Review Oncology

Advances in the molecular genetics of gliomas - implications for classification and therapy

Guido Reifenberger et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2017)

Review Cell Biology

Oncogenic Activities of IDH1/2 Mutations: From Epigenetics to Cellular Signaling

Laurence M. Gagne et al.

TRENDS IN CELL BIOLOGY (2017)

Article Genetics & Heredity

Mutational landscape and clonal architecture in grade II and III gliomas

Hiromichi Suzuki et al.

NATURE GENETICS (2015)

Article Genetics & Heredity

An Analysis of the Prognostic Value of IDH1 (Isocitrate Dehydrogenase 1) Mutation in Polish Glioma Patients

Marzena Anna Lewandowska et al.

MOLECULAR DIAGNOSIS & THERAPY (2014)

Article Neurosciences

A new sensitive PCR assay for one-step detection of 12 IDH1/2 mutations in glioma

Aurelie Catteau et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)

Review Cell Biology

What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer

Julie-Aurore Losman et al.

GENES & DEVELOPMENT (2013)

Article Clinical Neurology

Value and Limitations of Immunohistochemistry and Gene Sequencing for Detection of the IDH1-R132H Mutation in Diffuse Glioma Biopsy Specimens

Matthias Preusser et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)

Article Genetics & Heredity

Prognostic Value of IDH1 Mutations Identified with PCR-RFLP Assay in Glioblastoma Patients

Mateusz Bujko et al.

MOLECULAR DIAGNOSIS & THERAPY (2010)

Article Clinical Neurology

Analysis of the IDH1 codon 132 mutation in brain tumors

Joerg Balss et al.

ACTA NEUROPATHOLOGICA (2008)

Review Medicine, General & Internal

Malignant gliomas in adults

Patrick Y. Wen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Multidisciplinary Sciences

An integrated genomic analysis of human glioblastoma Multiforme

D. Williams Parsons et al.

SCIENCE (2008)

Article Medicine, General & Internal

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

R Stupp et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)